Boston Scientific Gets Green Light From NICE For Prostate Treatment
This article was originally published in Clinica
Executive Summary
A new guidance from the UK’s National Institute for Health and Care Excellence (NICE) concludes that adoption of Boston Scientific’s GreenLight XPS laser therapy system to treat non-high-risk benign prostatic hyperplasia patients could significantly reduce costs for the National Health Service.